Major League Baseball announced on Wednesday that New York Mets second baseman, Robinson Cano, has tested positive for performance enhancing drugs for the second time in his career.
As a result, Cano will be suspended for the entire 2021 season without pay.
BREAKING: Mets second baseman Robinson Canó has received a 162-game suspension without pay after testing positive for Stanozolol.
— Anthony DiComo (@AnthonyDiComo) November 18, 2020
Stanozolol is an anabolic steroid that can increase muscle growth for athletes. The drug received increased attention in the mid-2000s when it was reported as the PED used by Rafael Palmeiro. More recently, it led to the suspension of Ervin Santana in 2015.
This suspension is the second of Cano’s career, as he missed 80 games in the 2018 season when he tested positive for Furosemide. Cano, who just turned 38 in October, will still have two years remaining on his contract once his suspension is lifted. Meanwhile, the Mets will not have to pay Cano his $24 million for the 2021 season.
If Cano had any shot at the Hall of Fame, even with the first suspension, that door is now firmly closed.